Accelerating Antiviral Discovery with Data Science

In the quest to preempt the next global pandemic, Axle’s data science prowess has been instrumental in the Antiviral Program for Pandemics (APP). Faced with the daunting task of evaluating millions of images to identify potential antiviral compounds, our team’s expertise in advanced data analysis has proven essential in navigating this complex, data-intensive terrain.


Data Science as a Catalyst in Antiviral Research


Our response to the APP challenge was to construct scalable visualization pipelines and an interactive viewer capable of managing and interpreting the vast datasets produced by high-throughput drug screening. Utilizing state-of-the-art machine learning and deep learning techniques, we automated critical analysis processes. This strategic application of technology enabled us to sift through over 1.3 million images, identifying promising compounds with unprecedented speed and accuracy.

Transforming Drug Discovery with Machine Intelligence


The deployment of our solution marked a paradigm shift in the APP, establishing a novel protocol for high-volume assay analysis. Our advancements led to a 20-fold reduction in quality assurance and control visualization time and a 100-fold decrease in the discovery cycle time. In the race against emerging viral threats, such enhancements in data processing are not just improvements; they are essential leaps forward in developing timely treatments.

Pioneering the Future of Pandemic Preparedness with Axle


Axle’s contributions to the APP underscore our unwavering commitment to research excellence and innovation. Through our sophisticated data science capabilities, we are not just analyzing data; we are unlocking the potential to save lives by identifying treatments faster than ever before. In partnership with Axle, embrace the power of data science to transform your research and prepare the world for the challenges of tomorrow.